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Introduction 
Over 200 million people suffer from osteoporosis 
worldwide and is considered as a major health concern.1 
Osteoporosis is considered to be the 2nd most critical 
health problem by the World Health Organization. In 
Pakistan the prevalence of osteoporosis is suggested to 
be 9.1 million and it is further estimated that this figure 
was projected to rise by 11.3 million by the year 2020 
overburdening an already resource constrained 
environment.2 These figures suggest a major burden of 
osteoporosis in health sector of Pakistan. 
Bisphosphonates have been the first line therapy for 
management of osteoporosis for the past 20 years.3,4 They 
reduce osteoclastic bone resorption and the net result is a 
rapid and substantial decrease in bone turnover markers 
resulting in a modest increase in bone mineral density 
(BMD).5 It has been proposed that severe and prolonged 
suppression of bone turnover may impair the ability of 
bone re-modelling leading to an accumulation of micro 
damage and reduction of bone strength5-7 resulting in 
iatrogenic fractures. 
Atypical femoral fractures (AFFs) are defined as 
atraumatic or low-energy trauma fractures located in the 
sub-trochanteric region or femoral shaft.8 Patients usually 
present with a history of prodromal pain in the affected 
thigh, months prior to the actual injury which should 
prompt a physician to ask specifically for bisphosphonate 
use and then correlate with the radiology. Radiological 
features of AFFs are unique and include a simple 
transverse pattern with a uni-cortical break in an area of 
cortical hypertrophy.7 The diagnosis of AFFs specifically 
excludes femoral neck fracture, high impact trauma 
related fractures, pathological fractures associated with 
primary or secondary tumours, intertrochanteric 
fractures, and peri-prosthetic fractures.9 American Society 
for Bone and Mineral Research (ASBMR) has devised 
criteria for diagnosing an atypical fracture with major and 
minor features.10 Few drugs like bisphosphonates, 
glucocorticoids, proton- pump inhibitors and medical 
conditions such as diabetes, rheumatoid arthritis and 
vitamin D deficiency are included in the minor criteria.10 
Understanding the scarce literature and need for 
evaluation of these fractures this study was carried out for 
better understanding of the outcomes of surgically 
managed AFFs. 
Materials and Methods 
This study was a retrospective observational study 
conducted at Aga Khan University Hospital, Karachi, 
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Abstract 
Objective: To assess the functional and radiological outcomes in a unique class of fractures i.e. atypical femur 
fractures and to assess the effects of osteoblastic agents in healing. 
Methods: It is a retrospective observational study conducted at Aga Khan University Hospital, Karachi, Pakistan. All 
patients with atypical femur fractures who were surgically managed with intramedullary nailing from January, 2013 
to June, 2017 and with a follow-up till December 2019, were included in the study. Radiological outcomes were 
expressed as mean healing time and functional outcomes were recorded as mean Short Musculoskeletal Functional 
Assessment (SMFA) score. 
Results: A total of twenty-four patients were included in this study. Mean age of patients was 65.8 ± 8 years. Mean 
healing time was 10 ±3.2 months post operatively. Two patients underwent redo procedures. No other 
complications like paresthesia or weakness was observed in any patients. All the patients reported a good score on 
SMFA ranging from 19% to 31%. 
Conclusion:  Intra-medullary nailing shows a promising result in treatment of atypical femur fractures. Use of post-
operative osteoblastic supplements showed statistically significant results with early healing time (p=0.008 [95% 
CI]). 
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Pakistan after the institutional ethics review committee 
approval (ERC# 4759-Sur-ERC-17). Patients who were 
diagnosed for AFFs according to the ASBMR criteria10 and 
surgically managed with intra medullary nail between 
January, 2013 to June, 2017 were included in this study 
and data was analyzed after final follow-ups of all patients 
in December 2019. Sample size was calculated via WHO 
sample size calculator tool estimating population 
proportion of 0.9811 with absolute precision required of 
0.06, the sample size required for the study was 21 
patients. We included 24 patients in our study. Patient's 
demographic data including age, gender, occupation, 
duration of previous bisphosphonate use, mechanism of 
injury, fracture site of femur either sub-trochanteric or 
femur shaft, duration of surgery and post-operative use of 
bone remodeling agents were collected from the 
patients' charts and recorded on a preformed structured 
proforma. Serial radiographs were viewed to ascertain the 
fracture healing and consolidation on regular follow-ups. 
Patients were followed for a minimum period of 24 
months post operatively. Short Musculoskeletal 
Functional Assessment (SMFA) score12 was calculated via 
telephonic interview after verbal consent and used to 
assess the functional outcome of patients with a lesser 
score indicating better outcome. Categorical variables 
were recorded as frequency and percentages and chi-
square test or Fischer exact test was applied for analysis. 
Continuous variables were expressed as means with 
standard deviation, Data was checked for normality via 
Shapiro-Wilk test and student t-test was applied to 
compare means for analysis. A p-value of less than 0.05 
was considered significant for inferential analysis. 
Statistical package for the social sciences (SPSS) version 
20 was used for all analysis. 
Results 
A total of 24 patients were included in this study of whom 
21 were females and 3 were males. Mean age of the 
patients was 65.5±8 years. Majority of the patients 
sustained ground level fall. Twenty (83.3%) fractures 
occurred in sub-trochanteric region while 4 (16.7%) were 
femoral shaft fractures. Five patients out of 24 (20.8%) had 
a history of steroid use. Twenty-two patients took 
bisphosphonates for osteoporosis while 2 patients had 
never used them. Mean duration for bisphosphonates 
usage was 6.4±1.3 years. None of the patients took any 
other medication for osteoporosis prior to the fracture. Six 
patients reported a history of prodromal thigh pain with a 
mean duration of 1.6± 0.7 months (Table-1). 
All the patients were surgically managed with 
intramedullary nailing device (Figure-1 & 2). Mean 
duration of hospital stay was 6.75 ±2.3 days. Mean time 
for fracture healing was 10.8 ± 3.2 months. Five (20.83%) 
patients had dynamization of nail 3 months after index 
surgery. Two (8.3%) patients underwent additional 
procedures at 5th and 7th month respectively due to 
delayed union and were subjected to bone grafting. Both 
patients healed after 4 months of second surgery. All the 
patients reported a good score on SMFA with mean 
26.29% ± 2.89 (range 19% to 31%). Mean follow up time 
was recorded as 26.4±2.75 months (Range 24-35). All the 
patients stopped using bisphosphonate after surgery. 
Interestingly accelerated fracture healing was associated 
with use of osteoblastic agents like Strontium Ranelate 
and Teriperatide which was given to the patients as per 
surgeons' discretion. Patients who used any osteoblastic 
supplements post operatively showed a better mean 
healing time of 7.2 ± 2 months while mean healing time 
of 12.7 ± 3.3 months was observed in those patients who 
were not prescribed any agent (p=0.008). Eleven patients 
were prescribed Strontium Ranelate as per treating 
surgeons' discretion while 6 used Teriparatide as 
osteoblastic agents. Patients using Strontium had a mean 
healing time of 7.36±2.1 months while for Teriparatide 
group it was 7.0±2 months. Comparison of Strontium and 
Teriparatide using patients and mean healing time was 
not found to be statistically significant (Table-2). 
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Table-1: Patient demographics and fracture characteristics. 
 
Variable                                                                                                                Mean/Count (%) 
 
Mean Age (years)                                                                                                          65.5±8.0 
Gender                                                                                                                                    
Male                                                                                                                                  3 (12.5%) 
Female                                                                                                                            21 (87.5%) 
Steroid Use                                                                                                                            
Yes                                                                                                                                     5 (20.8%) 
No                                                                                                                                     19 (79.2%) 
Mechanism of Injury                                                                                                        
Ground level fall                                                                                                           22 (91.6%) 
Non traumatic                                                                                                                 2 (8.3%) 
Prodromal Pain                                                                                                                  
Yes                                                                                                                                       6 (25%) 
No                                                                                                                                       18 (75%) 
Fracture location                                                                                                                
Sub-trochanteric                                                                                                          20 (83.3%) 
Femur shaft                                                                                                                     4 (16.6%)
Table-2: Stratified healing times according to osteoblastic agents. 
 
                                       Use of Supplement              Mean (months)             Significance 
 
                                                 Yes (n=17)                               7.24±2.0                                   
Healing time                          No (n=7)                               12.71± 3.3                            0.08 
(months)                         Strontium (n=11)                       7.36 ± 2.1                                  
                                          Teriparatide (n=6)                       7.00 ± 2.0                            0.73
Discussion 
Atypical femurs are not uncommon but still are tricky to 
pick and require prompt careful history taking and 
assessment. The mechanism of action and fracture 
pattern on radiographs are the key to correct diagnosis. 
Our study delineates various aspects of assessment 
including specific questions while taking history such as 
prodromal pain, bisphosphonates use and its duration. 
The association between long-term bisphosphonate use 
and unusual diaphyseal fractures was first described in 
2005 by Odvina et al.13 Many studies have documented 
this association14 while according to Rizzoli et al, this case 
is yet unproven.15 For the past 2 decades, 
bisphosphonates have been the main stay treatment for 
the prevention of osteoporosis related fractures. In year 
2005, it was reported that prolonged use of BP has 
association with an unusual diaphyseal fracture and later 
it was termed as atypical femoral fracture by ASBMR.16 
The first report from the ASBMR task force published in 
2010 showed lack of studies regarding management and 
outcomes for atypical femoral fractures.10 
Egol et al. had reported a good outcome of surgically 
managed atypical femoral fractures with 98% of fractures 
healing at 12 months, and 60% becoming pain free post-
operatively11 whereas in our study, mean healing time 
was 10 months. Ha et al. studied the necessity of surgical 
management for atypical femoral fractures and their 
study population reported a 100% healing rate after 
surgical fixation17 which is comparable to our study. 
A case series of 21 patients of atypical femoral fractures 
showed a positive relation with smoking and steroid use 
while all the fractures were managed with intra medullary 
nailing and only one had non-union and rest healed 
uneventfully.18 In our study none of the selected patients 
had history of smoking and 5 patients used steroids. 
There was no significant relationship found for the usage 
of steroids or cigarette smoking.  
Ekstrom et al reported 25% mortality at 2 year follow-up 
in patients managed surgically for atypical femoral 
fractures, while 52% did not achieve the pre-fracture 
quality of life.19 There were no reported mortality of 
subjects in our study. In our data the SMFA scores were 
reported to be good in patients with early healing time. 
High scores were encountered in patients with delayed 
union or who underwent additional procedures. Weil et.al 
conducted a study which showed much higher failure 
rates with intra medullary nailing for atypical femoral 
fractures and requiring revision surgery, 54% achieved 
fracture healing while 46% had to undergo a revision 
surgery.20 Subramanian et.al reported a good surgical 
outcome for atypical femoral fractures with all the 
patients having uneventful healing while only one 
fracture developed non-union requiring revision 
surgery.18 Our study results showed that only two 
patients had to undergo redo surgery due to non-union 
after initial management but later achieved union.  
There were no studies found to have comparison 
between usage of post-operative supplements like 
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Figure-1: (a & b) X-ray's pelvis AP and femur AP views of a 68 year old lady with trivial 
injury showing left sided sub-trochanteric fracture with oblique pattern. (c & d) 
Postoperative radiographs at 6 months follow up showing intra-medullary nail in situ 
and good healing at post-op 6 months.
Figure-2: (a & b) 72 year old lady 8 years on bisphosphonates had a low energy ground 
level fall , radiographs  show left sided sub-trochanteric fracture with oblique pattern 
and medial beak with cortical thickening pathognomic of atypical fracture. (c & d) Post-
operative radiographs at 6 month follow up showing intra-medullary nail in situ and 
good healing at post-op 6 months 21.
Teriperatide and Strontium. In our study we found an 
association between early fracture healing with use of 
osteoblastic drugs warranting better SMFA as compared 
to those who did not use it. Since this was an observation, 
further studies are required to look in this association 
more closely. 
The strengths of the study is its adequate follow up period 
to delineate union and occurrence of any re-fracture. 
Moreover it provides an association between use of 
osteoblastic agents and healing time. The limitations of 
our study were a small sample size, its retrospective 
nature, and the functional outcome assessed over a 
telephonic interview. 
Conclusion 
This study reported comparatively good outcome for 
patients with atypical femoral fractures when managed 
with intra-medullary nailing. Use of post-operative 
osteoblastic supplements showed statistically significant 
results with early healing time, hence warranting further 
prospective studies and randomized controlled trials to 
study the relationship and association of Teriparatide or 
Strontium Ranelate with healing after surgical 
management. 
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